Revel Health prints two figures on every product line — a first-month rate and the ongoing one — which is honest and is also the single easiest way for a comparison to go wrong. This row records the ongoing rate for both compounds, because that is the one a buyer pays in month two.
What Revel Health charges
NAD+: $169/mo — the ongoing rate, printed as "from"; the same line prints a lower first-month figure beside it, so a reader who compares the first month against another seller's ongoing rate compares two different things
Sermorelin: $149/mo — the ongoing rate, printed as "from", with a lower first-month figure printed on the same line
Revel Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two figures per line, and only one of them recurs
Each product line carries an ongoing monthly rate marked as a starting figure and, beside it, a lower figure for the first month.
Both are the seller's own published prices and both are true; they simply describe different months.
A comparison that recorded the first-month figure would rank this seller against other sellers' ongoing rates, which is not a comparison at all.
The ongoing rate is what is recorded here for both compounds, and the first-month figure is named in the qualifier so nothing is hidden.
A corporate suffix that is a pair of states
The only corporate-suffix match anywhere on this page turns out to be two state abbreviations sitting next to each other in a list.
That is the sixth distinct way a suffix match has turned out not to be a company in this comparison's research.
The previous five were an arbitration administrator, a clinician credential and two different web agencies' boilerplate.
None of them can be told apart from a real entity by the match alone, which is why this row's entity field is empty rather than wrong.
One figure, and what stands next to it
Every product line carries two figures — a lower first month and an ongoing monthly rate — and this row records the ongoing rate for both compounds, with the first-month figure named beside it.
There is no certificate to reach here because none is claimed, and the sweep that would have found one came back empty.
One hundred and thirty-seven of the two hundred and ten sellers here publish a figure somewhere on their own site, and this is one of them.
The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.
States, pharmacy and labs, counted
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares two of the sixteen compounds this site tracks, and one hundred and one sellers here declare more, so it is one of the narrower menus here.
Who it's for
Readers who want the ongoing rate rather than the promotional one.
Buyers comparing two compounds priced the same way by one seller.
Shoppers who want the consultation, medication and shipping described as one price.
Anyone who wants an introductory rate labelled rather than smuggled into a comparison.
Who should look elsewhere
Readers who want the operating company named.
Buyers who want the dispensing pharmacy named.
Anyone who needs a state footprint.
Shoppers looking for GHK-Cu, BPC-157, PT-141 or a wider peptide menu.
Strengths
Labels the first-month figure as such rather than presenting it as the ongoing rate
Publishes a figure on its own site with the unit recorded beside it
Keeps its peptide offer separate from its other lines on the page
Answers the category question in plain language rather than in a disclaimer
Trade-offs
Publishes no company name; the only corporate-looking string on the page is a pair of state abbreviations
Publishes no corporate entity, so there is no company a reader can look up
Publishes no state list and names no dispensing pharmacy
Describes no lab work as included in what it charges
How we verified this
Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Recorded the ongoing monthly rate rather than the first-month rate for both compounds, and named the first-month figure in each qualifier so neither is hidden.
Read the sentence around the only corporate-suffix match on the page and found it is a pair of state abbreviations, so the entity field was left empty.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.
A provider to compare Revel Health against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.